To further explore the mechanism underlying LINC01089, we assessed whether LINC01089 could suppress EMT in NSCLC via targeting the miR-27a–SFRP1-Wnt/β-catenin axis. The gene discussed is SFRP1; the disease is non-small cell lung carcinoma.